You have 9 free searches left this month | for more free features.

liposome

Showing 1 - 25 of 678

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Lung Cancer Trial in Shanghai (Bupivacaine Liposome SAPB, Traditional TPVB)

Recruiting
  • Lung Cancer
  • Bupivacaine Liposome SAPB
  • Traditional TPVB
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Nov 15, 2023

Relapsed/Refractory Multiple Myeloma Trial in Suzhou (Mitoxantrone HCl liposome/Dexamethasone/daratumumab)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Mitoxantrone hydrochloride liposome/Dexamethasone/daratumumab
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
May 4, 2023

Acute Myeloid Leukemia Trial in Tianjin ((cytarabine: daunorubicin) liposome for injection, Vyxeos)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (cytarabine: daunorubicin) liposome for injection
  • Vyxeos
  • Tianjin, China
    Institute of Hematology and Hospital of Blood Disease, Chinese A
Mar 24, 2023

Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)

Active, not recruiting
  • Bioequivalence
  • Amphotericin B liposome for injection
  • AmBisome
  • Haikou, Hainan, China
    Haikou people's Hospital
Jun 12, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • (no location specified)
May 29, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 1, 2023

DLBCL Trial in Jinan (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome Injection
  • Jinan, Shandong, China
    Affiliated Cancer Hospital of Shandong First Medical University
May 16, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

T Cell Lymphoma Trial (Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen)

Not yet recruiting
  • T Cell Lymphoma
  • Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen
  • (no location specified)
Mar 6, 2023

Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)

Not yet recruiting
  • Recurrent Metastatic Nasopharyngeal Carcinoma
  • (no location specified)
Jan 29, 2023

Lower Eyelid Steatoblepharon Trial in Newport Beach (POLAT-001, Placebo)

Recruiting
  • Lower Eyelid Steatoblepharon
  • Newport Beach, California
    Medical Associates, Inc.
Jun 29, 2023

Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
  • (no location specified)
Aug 17, 2023

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • Mitoxantrone Hydrochloride Liposome Injection
  • (no location specified)
Sep 20, 2022

Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)

Not yet recruiting
  • Relapsing Multiple Sclerosis
  • Mitoxantrone Hydrochloride Liposome Injection
  • Beijing, Beijing, China
    Xuanwu Hospital Capital Medical University
Aug 9, 2022

Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)

Recruiting
  • Lymphoma, Solid Tumors
  • Mitoxantrone Hydrochloride Liposome
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 14, 2022

Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)

Recruiting
  • Desmoid Tumor
  • Liposome doxorubicin
  • Saline Solution
  • GuangZhou, Guangdong, China
    Sun Yat-sen University cancer center
Sep 29, 2022

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Diffuse Large B-cell Lymphoma Trial in Wuhan (Mitoxantrone Hydrochloride Liposome, Rituximab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone Hydrochloride Liposome
  • +2 more
  • Wuhan, Hubei, China
    Department of Hematology Tongji Hospital, Tongji Medical College
Oct 7, 2022

Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)

Not yet recruiting
  • Rhabdomyosarcoma, Child
  • (no location specified)
Jul 13, 2022

Peripheral T Cell Lymphoma Trial in Zhejiang (Mitoxantrone liposome?Chidamide?Azacitidine)

Recruiting
  • Peripheral T Cell Lymphoma
  • Mitoxantrone liposome态Chidamide态Azacitidine
  • Zhejiang, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 9, 2022

Advanced Solid Tumors Trial in United States (FF-10850 Topotecan Liposome Injection)

Recruiting
  • Advanced Solid Tumors
  • FF-10850 Topotecan Liposome Injection
  • Scottsdale, Arizona
  • +5 more
Oct 19, 2022

Advanced Solid Tumor Trial (Mitoxantrone Hydrochloride Liposome injection, Capecitabine, Albumin-paclitaxel)

Not yet recruiting
  • Advanced Solid Tumor
  • Mitoxantrone Hydrochloride Liposome injection
  • +2 more
  • (no location specified)
Apr 18, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial (Mitoxantrone Hydrochloride Liposome)

Not yet recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • Mitoxantrone Hydrochloride Liposome
  • (no location specified)
Apr 19, 2022